| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/18/2004 | WO2004022696A2 Fibrin cell supports and methods of use thereof |
| 03/18/2004 | WO2004022588A1 Variants of the major allergen phl p 1 from timothy grass |
| 03/18/2004 | WO2004022579A2 Cellular delivery of natriuretic peptides |
| 03/18/2004 | WO2004022575A2 Bioinformatics analysis of cellular effects of artificial transcription factors |
| 03/18/2004 | WO2004022089A1 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 03/18/2004 | WO2004022084A1 A method of modulating cellular activity and molecules for use therein |
| 03/18/2004 | WO2004022077A1 Methods and compositions for tissue regeneration |
| 03/18/2004 | WO2004021995A2 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy |
| 03/18/2004 | WO2004021977A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/18/2004 | WO2004021772A2 Immune cloning and uses thereof |
| 03/18/2004 | WO2004011601A8 Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof |
| 03/18/2004 | WO2004007697A3 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 03/18/2004 | WO2004003186A3 Subtilases and subtilase variants having altered immunogenicity |
| 03/18/2004 | WO2003102127A3 Human 5-ht7 receptor promoter sequence |
| 03/18/2004 | WO2003099995A3 Murine ortholog of the human disrupted-in-schizophrenia 1 gene |
| 03/18/2004 | WO2003095628A3 Control of es cell self renewal and lineage specification, and medium therefor |
| 03/18/2004 | WO2003093426A3 In vitro mutagenesis, phenotyping, and gene mapping |
| 03/18/2004 | WO2003078462A3 Cells transfected with a nucleotide sequence encoding glp-1 and secreting insulin in a glucose-dependent manner |
| 03/18/2004 | WO2003076950A3 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders |
| 03/18/2004 | WO2003072751A3 Expression system for human brain-specific voltage-gated sodium channel, type 1 |
| 03/18/2004 | WO2003070965A3 The eaat2 promoter and uses thereof |
| 03/18/2004 | WO2003068961A3 Method to modify differentiation of pluripotential stem cells |
| 03/18/2004 | WO2003065984A3 Methods and compositions for treating cardiovascular disease |
| 03/18/2004 | WO2003054197A3 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 03/18/2004 | WO2003043571A3 Method for extending the useful shelf-life of refrigerated red blood cells by nutrient supplementation |
| 03/18/2004 | WO2003042723A3 Optical cell guidance method and apparatus |
| 03/18/2004 | WO2003040305A3 Porcine adenovirus e1 and e4 regions |
| 03/18/2004 | WO2003038039A3 Novel cell-based assays for g-protein-coupled receptor-mediated activities |
| 03/18/2004 | WO2003032813A3 Methods for the treatment of carcinoma |
| 03/18/2004 | WO2003028630A3 Methods and compositions for modulating interleukin-21 receptor activity |
| 03/18/2004 | WO2003026670A3 Method for inhibiting the proliferation of hepatic stellate cells with a ligand of the low affinity glucocorticoid binding site (lags) |
| 03/18/2004 | WO2003022202A3 Compositions and methods for treatment of cancer |
| 03/18/2004 | WO2003007869A3 Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres |
| 03/18/2004 | WO2003007800A8 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 03/18/2004 | WO2002103024A3 Stabilized proteins with engineered disulfide bonds |
| 03/18/2004 | WO2002102972A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 03/18/2004 | WO2002095034A9 A retinoic acid metabolizing cytochrome p450 |
| 03/18/2004 | WO2002090567A9 Sperm-specific cation channel, and uses therefor |
| 03/18/2004 | WO2002085419A3 Bifunctional-modified hydrogels |
| 03/18/2004 | WO2002072768A3 ISOGENIC ss-CATENIN CELL LINES, AND METHODS OF MAKING AND USING SAME |
| 03/18/2004 | WO2002055694A3 Discriminative nucleic acid analysis using clone sequence signatures |
| 03/18/2004 | US20040055040 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins |
| 03/18/2004 | US20040055039 Expression vector coding regulatory sequence for transcription of heterologous nucleotide sequences in fruit of plants; tissue engineering |
| 03/18/2004 | US20040055037 Plasmid comprising, internal ribosome entry sites and capable of amplification, expression and polycistronic cap independent translation; genetic engineering |
| 03/18/2004 | US20040055036 Toxin genes from the bacteria xenorhabdus nematophilus and photorhabdus luminescens |
| 03/18/2004 | US20040055035 Hybrid maize plant & seed 38F10 |
| 03/18/2004 | US20040055032 Pyrophosphatase stress-related proteins and methods of use in plants |
| 03/18/2004 | US20040055030 Sperm cell processing and preservation systems |
| 03/18/2004 | US20040055028 Urocortin-deficient mice and uses thereof |
| 03/18/2004 | US20040055024 Conditional mutants of influenza virus M2 protein |
| 03/18/2004 | US20040054410 Porosity biodegradation polymer shapes |
| 03/18/2004 | US20040054158 GL50 molecules and uses therefor |
| 03/18/2004 | US20040054149 Modified proteolytic enzyme for treatment of osteoarthritis |
| 03/18/2004 | US20040054142 Cripto tumour polypeptide |
| 03/18/2004 | US20040054140 Neuronal differentiation regulating factor for treatment of central nervous system disorders |
| 03/18/2004 | US20040054139 Chimeric genetically engineered DNA viral protein for use in immunotherapy and vaccine development |
| 03/18/2004 | US20040054136 Comprises nucleotide sequences coding transporter associated with antigen processing-like polypeptides (human TAP-like) for diagnosis and treatment of infection, tumors and autoimmune diseases |
| 03/18/2004 | US20040054135 Calcineurin polypeptide for diagnosis and treatment of cardiovascular disorders |
| 03/18/2004 | US20040054134 Hcv ns2/3 fragments and uses thereof |
| 03/18/2004 | US20040054133 Multiple sclerosis-related superantigen |
| 03/18/2004 | US20040053869 Stem cell differentiation |
| 03/18/2004 | US20040053867 Nucleotide sequences that code for transport proteins; modulation of excitatory amino acids or signal tranduction; detoxification |
| 03/18/2004 | US20040053863 Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy |
| 03/18/2004 | US20040053829 Polypeptide having preferably antitumoral and/or immunomodulating cytokine properties, which can be activated by processing in vivo comprising a central region with specific biological activity |
| 03/18/2004 | US20040053409 Using multilayered collagen matrix to propagate, culture and freeze store fibroblast and/or keratinocytes; tissue engineering and wound healing agents |
| 03/18/2004 | US20040053408 Comprises anticoagulant/thrombolytic agent for selective dissolution of fibrin clots |
| 03/18/2004 | US20040053407 Propagating mucified oocyte and/or urogential complexes in oil-free broth; genetic and tissue engineering; in vitro fertilization |
| 03/18/2004 | US20040053406 Pluripotent embryonic stem (es) cell lines, improved methods for their production, and their use for germ line transmission and for the generation of genetically modified animals |
| 03/18/2004 | US20040053390 Generating mutant aminoacyl transfer RNA synthetase for de novo design of artificial proteins |
| 03/18/2004 | US20040053386 Terpene synthase having a region with 20% or greater sequence identity to specific residues of perferential amino acid sequence, and such synthase containing nine alpha-carbon having interatomic distance +-2.3 Angstroms between alpha C |
| 03/18/2004 | US20040053381 Polyhydroxyalkanoates for in vivo applications |
| 03/18/2004 | US20040053379 Method of producing polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs |
| 03/18/2004 | US20040053370 Comprises chimeric glucagon-like peptides-1 (GLP-1) for treating obesity and non-insulin dependent diabetes mellitus |
| 03/18/2004 | US20040053367 Lipid-associated molecules |
| 03/18/2004 | US20040053366 Comprises nucleotide sequences coding leptin chimeric polypeptide for treatment and prevention of weight and cardiovascular disorders |
| 03/18/2004 | US20040053364 Genetically engineered immunoglobulin receptor for modulating humoral response in transplant patients |
| 03/18/2004 | US20040053363 Preparing multicompoment polypeptide for treating cancer and infections; immunotherapy |
| 03/18/2004 | US20040053362 Preparing fusion protein comprising multiple functional protein domains via homologous recombination |
| 03/18/2004 | US20040053361 Nucleic acid construct useful for expressing transgenes in particular in embryonic stem cells |
| 03/18/2004 | US20040053360 Preparing proteolytic polypeptide comprising amino acid attachment at carboxy-terminal for reducing odors generated when washing textiles solied with milk fat |
| 03/18/2004 | US20040053359 Preparing multicompoment polypeptide for treating cancer and infections; immunotherapy |
| 03/18/2004 | US20040053358 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/18/2004 | US20040053357 Nucleic acid encoding kv10.1 a voltage-gated potassium channel from human brain |
| 03/18/2004 | US20040053344 Using human leukocyte antigen protein-f to classify and identify cell proliferative disorders |
| 03/18/2004 | US20040053329 Endoglin-specific polypeptide, production and use thereof |
| 03/18/2004 | US20040053314 ADAM20 (SVPH1-26) DNA and polypeptides |
| 03/18/2004 | US20040053307 Comprises dual specificity membrane fusion proteins for treatment of transplant, allergenic, autoimmune and immunosuppressive disorders |
| 03/18/2004 | US20040053299 Regulated activation of cell-membrane receptors by metal-chelating agonists |
| 03/18/2004 | US20040053296 Method for localizing polypeptide on cell surface |
| 03/18/2004 | US20040053293 Novel core 2 beta-1,6-N-acetylglycosaminyltransferase gene |
| 03/18/2004 | US20040053281 Comprises enzymatic polypeptide associated with fatty acid metabolism for diagnosing, treating and preventing cancer, neurodegenerative, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 03/18/2004 | US20040053278 Smad6 and uses thereof |
| 03/18/2004 | US20040053272 Methods of constructing a model of cellular development and differentiation using homozygous stem cell systems, methods of assessing and cataloging proteins expressed therein, cDNA libraries generated therefrom, and materials and methods using same |
| 03/18/2004 | US20040053262 Supressor gene |
| 03/18/2004 | US20040053259 Comprises methylated antisense oligonucleotide sequence for regulation of urokinase type plasminogen activator and treatment of cancer |
| 03/18/2004 | US20040053243 High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa |
| 03/18/2004 | US20040053238 Comprises xylanolytic polypeptides for use in food processing/thickening, detergents, textile treatment and paper making |
| 03/18/2004 | US20040053233 Identifying antagonist and/or agonist of neovascularization for treatment and prevention of cancer, reproductive, skin, visual and wound healing disorders |
| 03/18/2004 | US20040053224 Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency-encoded glycoprotein |
| 03/18/2004 | US20040053207 Preservation of cells |